• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重肺动脉高压作为系统性红斑狼疮的首发表现:一例病例报告及文献综述

Severe Pulmonary Hypertension as Initial Presentation of SLE: A Case Report and Literature Review.

作者信息

Kiani Rabia, Siddiqui Muhammad Danial, Tantoush Hamza

机构信息

Department of Internal Medicine, University of South Dakota, Vermillion, SD, USA.

出版信息

Case Rep Rheumatol. 2020 May 15;2020:6014572. doi: 10.1155/2020/6014572. eCollection 2020.

DOI:10.1155/2020/6014572
PMID:32509370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7245690/
Abstract

Severe pulmonary artery hypertension (PAH) is a rare initial presentation of systemic lupus erythematosus (SLE). SLE associated with PAH carries worse prognosis that isolated SLE. However, there has been improvement in mortality of the patients in the recent years owing to newer treatment options available. Early recognition remains of prime importance. We present here a case of young female who presented with severe pulmonary hypertension with right heart failure leading to cardiogenic shock and was found to have SLE. She was started on appropriate treatment; however, given the severity of her illness, the patient did not survive. This case highlights the importance of early recognition and prompt treatment of SLE-associated PAH, which might improve the survival rate in the patients.

摘要

重度肺动脉高压(PAH)是系统性红斑狼疮(SLE)罕见的初始表现。与PAH相关的SLE预后比单纯SLE更差。然而,由于有了新的治疗选择,近年来患者的死亡率有所改善。早期识别仍然至关重要。我们在此介绍一例年轻女性病例,该患者表现为重度肺动脉高压伴右心衰竭,导致心源性休克,最终被诊断为SLE。她开始接受适当治疗;然而,鉴于病情严重,患者未能存活。该病例强调了早期识别和及时治疗SLE相关PAH的重要性,这可能会提高患者的生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f9/7245690/44af256d7278/CRIRH2020-6014572.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f9/7245690/377bf21055ee/CRIRH2020-6014572.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f9/7245690/44af256d7278/CRIRH2020-6014572.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f9/7245690/377bf21055ee/CRIRH2020-6014572.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f9/7245690/44af256d7278/CRIRH2020-6014572.002.jpg

相似文献

1
Severe Pulmonary Hypertension as Initial Presentation of SLE: A Case Report and Literature Review.严重肺动脉高压作为系统性红斑狼疮的首发表现:一例病例报告及文献综述
Case Rep Rheumatol. 2020 May 15;2020:6014572. doi: 10.1155/2020/6014572. eCollection 2020.
2
Pulmonary arterial hypertension in SLE: what do we know?系统性红斑狼疮相关肺动脉高压:我们了解多少?
Lupus. 2013 Oct;22(12):1274-85. doi: 10.1177/0961203313505010.
3
Lupus-Associated Pulmonary Arterial Hypertension: Variable Course and Importance of Prompt Recognition.狼疮相关肺动脉高压:病程多变及早期识别的重要性
Case Rep Med. 2015;2015:328435. doi: 10.1155/2015/328435. Epub 2015 Jul 2.
4
Severe pulmonary arterial hypertension secondary to lupus in the emergency department: proactive intense care associated with a better short-term survival.急诊科狼疮继发的重度肺动脉高压:积极强化治疗与更好的短期生存率相关。
Int J Rheum Dis. 2015 Mar;18(3):331-5. doi: 10.1111/1756-185X.12409. Epub 2014 Jun 19.
5
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature.以重度肺动脉高压为首发表现的系统性红斑狼疮 1 例报告并文献复习
Clin Exp Rheumatol. 2014 Mar-Apr;32(2):267-74. Epub 2013 Dec 16.
6
Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry.与系统性红斑狼疮相关的肺动脉高压:来自法国肺动脉高压注册研究的结果。
Chest. 2018 Jan;153(1):143-151. doi: 10.1016/j.chest.2017.08.014. Epub 2017 Aug 26.
7
Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.系统性硬化症-红斑狼疮重叠综合征中的肺动脉高压
Ann Cardiol Angeiol (Paris). 2019 Oct;68(4):221-225. doi: 10.1016/j.ancard.2018.10.012. Epub 2019 Jan 23.
8
Pulmonary Arterial Hypertension (PAH) as the Initial Manifestation of Systematic Lupus Erythematosus (SLE): A Rare Presentation.肺动脉高压作为系统性红斑狼疮(SLE)的初始表现:一种罕见的情况。
Cureus. 2023 May 22;15(5):e39359. doi: 10.7759/cureus.39359. eCollection 2023 May.
9
Could pulmonary arterial hypertension be an active index of systemic lupus erythematosus? A successful case of SLE-PAH cured by methylprednisolone pulse therapy.肺动脉高压会是系统性红斑狼疮的一个活动指标吗?1例经甲泼尼龙冲击疗法治愈的系统性红斑狼疮合并肺动脉高压成功病例。
Lupus. 2014 Dec;23(14):1533-6. doi: 10.1177/0961203314552461. Epub 2014 Sep 26.
10
Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.基于 CSTAR-PAH 研究的系统性红斑狼疮相关肺动脉高压:基线特征和危险因素。
Int J Rheum Dis. 2019 May;22(5):921-928. doi: 10.1111/1756-185X.13478. Epub 2019 Feb 11.

引用本文的文献

1
Agranulocytosis in systemic lupus erythematosus: A case report.系统性红斑狼疮伴粒细胞缺乏症:一例报告
Clin Case Rep. 2022 Nov 15;10(11):e6511. doi: 10.1002/ccr3.6511. eCollection 2022 Nov.
2
Decreased low-density lipoprotein and the presence of pulmonary arterial hypertension among newly diagnosed drug-naïve patients with systemic lupus erythematosus: D-dimer as a mediator.初诊未用药的系统性红斑狼疮患者中低密度脂蛋白降低与肺动脉高压的存在:D-二聚体作为一种介质
Exp Ther Med. 2022 Jul 27;24(3):595. doi: 10.3892/etm.2022.11531. eCollection 2022 Sep.
3
Severe Pulmonary Artery Hypertension in Otherwise Silent Lupus: A Unique Hybrid Treatment Approach Using Hydroxychloroquine and Sildenafil.

本文引用的文献

1
Serological biomarkers as risk factors of SLE-associated pulmonary arterial hypertension: a systematic review and meta-analysis.血清生物标志物作为系统性红斑狼疮相关肺动脉高压的危险因素:一项系统综述和荟萃分析。
Lupus. 2017 Nov;26(13):1390-1400. doi: 10.1177/0961203317702255. Epub 2017 Apr 14.
2
Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies.系统性红斑狼疮与肺动脉高压:关联、风险及管理策略
Open Access Rheumatol. 2016 Dec 20;9:1-9. doi: 10.2147/OARRR.S123549. eCollection 2017.
3
The pathogenesis of pulmonary hypertension--an update.
隐匿性狼疮并发重度肺动脉高压:采用羟氯喹和西地那非的独特联合治疗方法
Cureus. 2022 May 27;14(5):e25411. doi: 10.7759/cureus.25411. eCollection 2022 May.
肺动脉高压的发病机制——最新进展
Swiss Med Wkly. 2015 Oct 19;145:w14202. doi: 10.4414/smw.2015.14202. eCollection 2015.
4
Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.成人肺动脉高压的药物治疗:CHEST指南与专家小组报告
Chest. 2014 Aug;146(2):449-475. doi: 10.1378/chest.14-0793.
5
Optimizing outcome in SLE: treating-to-target and definition of treatment goals.优化 SLE 结局:达标治疗及治疗目标的定义。
Autoimmun Rev. 2014 Jul;13(7):770-7. doi: 10.1016/j.autrev.2014.01.055. Epub 2014 Jan 27.
6
Definitions and diagnosis of pulmonary hypertension.肺动脉高压的定义和诊断。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032.
7
Updated clinical classification of pulmonary hypertension.肺动脉高压的最新临床分类。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41. doi: 10.1016/j.jacc.2013.10.029.
8
Targeted approaches to the treatment of pulmonary hypertension.靶向治疗肺动脉高压。
Ther Adv Respir Dis. 2012 Jun;6(3):147-59. doi: 10.1177/1753465812441849. Epub 2012 Mar 21.
9
The causes of death in Korean patients with systemic lupus erythematosus over 11 years.韩国系统性红斑狼疮患者 11 年以上的死亡原因。
Lupus. 2011 Aug;20(9):989-97. doi: 10.1177/0961203311402245. Epub 2011 Jun 23.
10
[Pulmonary arterial hypertension in systemic lupus erythematosus].[系统性红斑狼疮中的肺动脉高压]
Rev Med Interne. 2011 Nov;32(11):689-97. doi: 10.1016/j.revmed.2011.01.002. Epub 2011 Mar 3.